Is HIV up or down today?
HIV is up 0.46% today, last at 219.92. This stock moved +0.46% versus the prior close.
HIV · HIV
HIV (HIV) is trading at 219.92, up 0.46% on the session. HIV sits at the 50% mark of its 52-week range.
Leading the coverage: “GSK third quarter likely to be in line as RBC sees vaccine headwinds offset by HIV strength - Yahoo Finance UK” (Google News Earnings, 20d ago). HIV is +5.41% since story.
HIV trades on a trailing P/E of 19.7.
Analyst firms are mostly reiterating — no strong directional shift lately.
HIV is up 0.46% today, last at 219.92. This stock moved +0.46% versus the prior close.
Leading the coverage: “GSK third quarter likely to be in line as RBC sees vaccine headwinds offset by HIV strength - Yahoo Finance UK” (Google News Earnings, 20d ago). HIV is +5.41% since story. Dominant story: Two trials of Merck's investigational monthly HIV-prevention pill have finished adult enrollment. - Stock Titan (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Two trials of Merck's investigational monthly HIV-prevention pill have finished adult enrollment. - Stock Titan
Can Gilead (NASDAQ:GILD) Keep Its HIV Engine Running? - Kalkine Media
Gilead (GILD) Stock Rallies As Q3 Results Fuel HIV Growth Debate - Simply Wall St
Gilead's Inflammation Pipeline Could Extend Its Moat Beyond HIV and Oncology - Morningstar
GILD Beats Q3 Earnings on HIV Strength & Trodelvy Sales Growth - Zacks Investment Research